Kaley Wilson
Vorstandsvorsitzender bei Sitka Biopharma, Inc.
Profil
Kaley Wilson is currently the Chief Executive Officer at Sitka Biopharma, Inc. and a Director at Microbion Corp., Quark Venture, Inc., and Crohn's & Colitis Canada.
Previously, he was the Chief Executive Officer at ARTMS, Inc. from 2018 to 2019.
He holds a doctorate degree from the University of British Columbia.
Aktive Positionen von Kaley Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Direktor/Vorstandsmitglied | - |
Sitka Biopharma, Inc.
 Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Vorstandsvorsitzender | - |
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Private Equity Investor | 01.10.2016 |
| Crohn?s & Colitis Canada | Direktor/Vorstandsmitglied | 01.05.2021 |
Ehemalige bekannte Positionen von Kaley Wilson
| Unternehmen | Position | Ende |
|---|---|---|
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Vorstandsvorsitzender | 10.09.2019 |
Ausbildung von Kaley Wilson
| University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Health Technology |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Health Technology |
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | Health Technology |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Finance |
| Crohn?s & Colitis Canada |
